MO-PIERIANDX
2.11.2021 14:17:13 CET | Business Wire | Press release
PierianDx, the global leader in clinical genomics knowledge, announced that it closed on $30 million of new growth capital including equity financing and a term loan facility, which includes access to additional tranches for up to $17.5 million by 2022 and 2023, subject to certain conditions. The financing was led by healthcare investment firm OrbiMed with existing investors Health Catalyst Capital, Research Triangle Institute, Inova Health Systems, ATW Partners, and SJF Ventures also participating. The new capital will drive commercial expansion in response to increased demand as more healthcare organizations seek to provide high quality, affordable, faster care locally to their patients by internalizing next generation sequencing (NGS) testing capabilities.
PierianDx partners directly with providers, laboratories, and medical centers of all sizes to build advanced NGS testing capabilities on site using its assay-agnostic, advanced interpretation technology and enabling services. Founded in 2014 as a technology transfer spinout from Washington University in St. Louis, PierianDx has established partnerships with industry leaders and medical facilities around the world as they build or expand upon their advanced precision medicine programs using NGS technology.
“To manifest the full impact of genomics, we must routinely apply it in clinical settings,” states Rakesh Nagarajan, Founder, President, and Chief Technical and Visionary Officer of PierianDx. “Our interpretation technology and services lead the way by empowering medical facilities to understand a patient’s genetic variation, identify the best treatment options, and deliver the most precise care.”
"We are thrilled to work with OrbiMed and our existing investors as they share our vision for decentralized NGS testing that enables our laboratory and physician customers to better serve patients,” states Mark McDonough, CEO of PierianDx. "This capital will allow us to continue building a world-class team and deliver transformative solutions to leading healthcare organizations everywhere so that they can bring genomics into their communities.”
About PierianDx
PierianDx is a partner in precision medicine, enabling clinicians and medical facilities to advance clinical genomics programs and modernize patient care. We believe in the potential of genomics to transform human health, and are working to ensure that communities anywhere can experience the benefits. With advanced interpretation technology connected to the most comprehensive genomic knowledgebase, PierianDx empowers providers with genomic insights to fulfill the promise of precision care.
About OrbiMed
OrbiMed is a leading healthcare investment firm, with over $18 billion in assets under management. OrbiMed invests globally across the healthcare industry through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya and other key global markets.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211102005411/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Miro Announces Asia Hub in Singapore to Accelerate Growth Across the Region and Bring AI Collaboration to New Markets17.3.2026 02:00:00 CET | Press release
AI Innovation Workspace perfectly placed to help organisations maximise AI investment and accelerate innovation Miro®, the AI Innovation Workspace for teams, today announced plans to expand its operations in Asia, supporting organisations across the region in their AI transformation journey. Miro is investing in people, resources, and infrastructure as it targets growth in key markets, including Singapore, India, South Korea, and other Southeast Asia countries. As the global innovation centre of gravity shifts toward Asia – where R&D spending reached 45% of global investment in 2024 – the organisations leading this charge need tools and platforms built for the complexity and pace of modern innovation and collaboration. Miro's AI-powered innovation workspace is uniquely positioned to support this moment. Miro gives organisations the shared context layer they need to move from insight to execution faster than ever before. For Asia's most ambitious innovators, where speed-to-market and cr
IQM and Zurich Instruments Launch Real-Time Quantum Error Correction Demonstrator with NVIDIA NVQLink16.3.2026 22:24:00 CET | Press release
The demonstrator being built in this project delivers a clear path toward scalable and fault-tolerant quantum computers. The joint project integrates IQM’s superconducting quantum processor, Zurich Instruments’ ZQCS Quantum Control System, with the NVIDIA NVQLink platform to enable real-time error correction. This initiative establishes a foundation for standardized enterprise-ready quantum systems, and datacenter deployment. Today, IQM Quantum Computers and Zurich Instruments announce a joint project to build and operate a real-time quantum error correction (QEC) demonstrator, enabled by the NVIDIA NVQLink platform. This project marks a significant milestone toward scalable and fault-tolerant quantum computing designed for enterprise and datacenter deployment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316511715/en/ IQM and Zurich Instruments launch real-time quantum error correction demonstrator with NVIDIA NVQLink
Kinaxis Advances Large-Scale Supply Chain Optimization with NVIDIA AI16.3.2026 21:30:00 CET | Press release
Achieves up to 12X faster end-to-end planning performance in large-scale enterprise models Kinaxis® Inc. (TSX: KXS), a global leader in supply chain orchestration, today announced a new milestone in advancing large-scale supply chain optimization within the Kinaxis Maestro™ platform. Maestro already delivers high-performance optimization across complex global supply chains, and Kinaxis is now extending that leadership by leveraging GPU acceleration powered by NVIDIA cuOpt™ and NVIDIA AI infrastructure. As supply chains grow in scale and complexity, planning models must reconcile tens of millions of variables across extended time horizons and multiple planning levels. As model size expands, the number of potential decisions can scale into billions, dramatically increasing computational needs. Organizations are no longer constrained by insight alone. They are constrained by how quickly they can iterate. In testing on a large-scale semiconductor planning model with nearly 50 million decis
Lattice Joins NVIDIA Halos Ecosystem to Advance Safety for Physical AI with Holoscan Sensor Bridge16.3.2026 21:30:00 CET | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced it has joined the NVIDIA Halos AI Systems Inspection Lab ecosystem, the first ANSI National Accreditation Board (ANAB) accredited inspection lab for AI-driven physical systems. Announced at the NVIDIA GTC 2026, Lattice will engage with NVIDIA and other Halos ecosystem members to build Halos-certified Holoscan Sensor Bridge-based designs for physical AI and to help shape best practices as the industry evolves. “Physical AI is rapidly moving from controlled environments into the real world, where safety, reliability, and trust are paramount,” said Raemin Wang, Vice President, Segment Marketing, Lattice Semiconductor. “Through this collaboration, Lattice looks forward to contributing our expertise in low power FPGAs and award-winning solution stacks to enable scalable, trusted physical AI systems across robotics, industrial automation, and autonomous applications.” NVIDIA Halos is a comprehensive full
Lenovo Brings Production-Scale AI to Global Sports: Enhancing Fan Experience, Driving Revenue Growth, Boosting Performance, and Improving Operational Efficiency with NVIDIA16.3.2026 21:30:00 CET | Press release
Multiyear collaboration introduces new solutions spanning Sports Intelligence, Operations, and Media & Content. At NVIDIA GTC today, Lenovo (HKSE: 992) (ADR: LNVGY) announced an expanded multiyear collaboration with NVIDIA to help the global sports industry deploy production-scale AI across mission-critical environments, transforming live data into revenue growth, operational resilience, and real-time decision advantage. The global sports technology market is projected to grow from $23 billion in 2025 to more than $60 billion by 2030. Global sports events represent some of the most complex and demanding operating environments in any industry, combining unprecedented scale, technical sophistication, and public visibility. These events engage billions of viewers worldwide, generate and process petabytes of data in real time, and require highly coordinated, distributed operations across multiple countries, all within a context where reliability, resilience, and uninterrupted performance a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom